Start: 10 Nov 2021, 16:00
End: 10 Nov 2021, 17:00

Chair: Dr Rowena Sharpe, University of Birmingham, UK
Speaker: Dr Victoria Kunene, University Hospitals Birmingham
Speaker: Professor Munir Pirmohamed, University of Liverpool, UK
Speaker: Ms Emily Travis, NCRI Consumer Forum Member, UK

This session will provide an introduction into pharmacogenomics, how it is currently used in standard of care, and what the research pipeline looks like. Speakers will highlight what issues there are in initiating or progressing research, whether there are disparities in EDI to explore, and how we ensure uptake/national roll out. The discussion will focus on how we might move towards a world where we consider genomically predicting toxicity alongside cancer response, especially in a field where combination treatments are being explored with the potential for additional adverse toxicity. By the end of the session, delegates will learn about new opportunities and ideas to form new collaborations in this field.

Session labels:

Allied Health Professionals Clinicians Discovery / underpinning research Live Nurses Panel Patient experts Prevention and early detection Scientists Students Trainees / Early career researchers Treatment